Streetbeat News

Analyst Ratings

WOLF

Recent options trading activity for Wolfspeed (NYSE:WOLF) shows a bearish sentiment among big-money investors, with 59% of trades being bearish. The stock is currently trading at $7.56, down 8.14%, with a neutral RSI. Analysts have mixed ratings, with target prices ranging from $14 to $25.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 6:30 pm

CRLBF

CURLF

Cresco Labs, rated 'Overweight' by Zuanic & Associates, is positioned to benefit from regulatory changes and market growth in Ohio, Florida, and Pennsylvania. Despite trading at a discount, its financial stability and strategic positioning present a potential opportunity for investors.

Portfolio Pulse from Nicolás Jose Rodriguez

September 09, 2024 | 6:29 pm

FULC

RHHBY

RNA

BofA Securities has upgraded Fulcrum Therapeutics (FULC) from Underperform to Neutral, increasing the price target from $5 to $10, ahead of the phase 3 readout for losmapimod in treating FSHD. The study's success is debated due to a new endpoint, RWS, and potential competition from Avidity Biosciences and Roche.

Portfolio Pulse from Vandana Singh

September 09, 2024 | 6:28 pm

BCYC

Bicycle Therapeutics shares are experiencing an upward trend as Cantor Fitzgerald reiterated an Overweight rating and Needham maintained a Buy rating on the stock.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:24 pm

VEEV

JP Morgan analyst Anne Samuel maintains a Neutral rating on Veeva Systems (NYSE:VEEV) and raises the price target from $203 to $208.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:21 pm

PHR

JP Morgan analyst Anne Samuel maintains an Overweight rating on Phreesia (NYSE:PHR) and raises the price target from $27 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:20 pm

CCSI

Consensus Cloud Solutions shares fell after JP Morgan downgraded the stock from Neutral to Underweight.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:19 pm

PINC

JP Morgan analyst Anne Samuel maintains a Neutral rating on Premier (NASDAQ:PINC) and lowers the price target from $21 to $19.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:16 pm

ASAI

JP Morgan analyst Joseph Giordano has downgraded Sendas Distribuidora (NYSE:ASAI) from Overweight to Neutral, setting a price target of $10.5.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:11 pm

AZN

ELVN

PFE

HC Wainwright initiated coverage on Enliven Therapeutics (NASDAQ:ELVN), highlighting its promising leukemia candidate ELVN-001, which could challenge existing treatments from Pfizer and AstraZeneca. The analyst gave a Buy rating with a $37 price target, noting potential peak sales of over $500 million.

Portfolio Pulse from Vandana Singh

September 09, 2024 | 6:05 pm